HOME › DRUGS › ETEPLIRSEN
ACTIVE SUBSTANCE / INN

ETEPLIRSEN

Brand name(s): EXONDYS 51, Exondys
FDA LISTED
EMA LISTED
PRESCRIPTION
REFUSED
NDA206488
Muscular Dystrophy, Duchenne
ACTIVE SUBSTANCE
Eteplirsen
REGULATORS
FDA · EMA
SPONSORS / MAH
AVI Biopharma International Ltd, SAREPTA THERAPS INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EXONDYS 51NDA206488SAREPTA THERAPS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ExondysAVI Biopharma International LtdRefusedMuscular Dystrophy, Duchenne

FULL INTELLIGENCE ON ETEPLIRSEN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →